You searched for "interview"
Deliberate darkness: The systematic weaponisation of blinding in global protests
As eyecare professionals, we spend our entire professional lives fighting to preserve light. We train to master the delicate microscopic topography of the cornea, the retina and the optic nerve, all with the objective of saving our patients from the...High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...Eyecare challenges in the Middle East: Priorities of a global ophthalmology task force
Global ophthalmology is a rapidly evolving, multidisciplinary field that integrates clinical practice, research, and policy at national and international levels. One of its main objectives is to improve eyecare equity worldwide by preventing avoidable vision impairment. Since the launch of...Eye News announces new partnership
We are delighted to announce we are now media partners of King's College London Ophthalmology Society.Could you mentor budding ophthalmologists in London?
King’s College London Ophthalmology Society is looking for ophthalmologists from any level based in a London hospital that would be able to give guidance and support to a medical student.Introducing the Interest in Ophthalmology Association
We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.Biotech Healthcare Successfully Concludes Global Phakic Users Meeting 2024 in Barcelona
October 3, 2024 – Celebrating its 25th anniversary, Biotech Healthcare hosted the Global Phakic Users Meeting 2024 at the stunning Joan Miró Foundation in Barcelona on 5th September. Bringing together over 150 ophthalmologists from 28 countries, the event showcased Biotech's...David Reed MP met with clinical teams in Exeter who are supporting NHS ophthalmology services
MP for Exmouth and Exeter East visited SpaMedica Exeter to discuss how independent sector capacity is supporting NHS ophthalmology services across the country. SpaMedica is one of the UK’s largest independent providers of NHS-funded ophthalmology care, specialising in cataract surgery...Clinical and management strategies in glaucoma practice: perspectives from international glaucoma specialists
Management options and outcomes in glaucoma practice were reviewed at the 7th Moorfields International Glaucoma Symposium, held in London on 24 January 2015. This article summarises perspectives from international glaucoma specialists on debated issues in topical therapy, glaucoma surgery, diagnostic...
